arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Community Healthcare Trust Inc

CHCT

$14.25 ▼ -0.17 (-1.18%) at close

11 Visible periods

34 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Bearish

auto_awesome

Analytical Summary

Community Healthcare Trust Inc faces fundamental challenges with weakness in Debt to Equity. The fundamentals warrant careful consideration of downside risks.

Market Cap $382.7M

Dividend Yield 13.23%

Revenue Growth None

Op. Margin —

ROIC None

FCF / Share None

Trailing P/E 178.1x

Price / Book 0.9x

FCF Yield —

Debt / Equity 1.24

info Valuation on last close. End-of-day price, Sep 23, 2026.

11-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$112.84M

↑ +15.5% —

Net Income Profit after all expenses

$5.10M

↑ +260.4% —

Long-Term Debt Long-term obligations

$532.20M

↑ +9.5% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Debt to EquityDebt to Equity is concerning (bottom quartile)

Health Breakdown

Returns ↓

Financial Health ↑

Dividend History

Dividend / share · sourced from SEC filings

$1.89 Latest / share

+2.2% YoY

+2.4% 9-yr CAGR

FY 2015

FY 2016

$1.56

FY 2017

$1.60

FY 2018

$0.41

FY 2019

$0.42

FY 2020

$0.43

FY 2021

$1.76

FY 2022

$1.80

FY 2023

$1.84

FY 2024

$1.89

FY 2025

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 7 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2014 10-K ↗	FY 2015 Mar 27, 2014 10-K ↗
Revenue Growth YoY (%)	—	—	15.5% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+211%)	7.8% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+57%)	19.7% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+294%)	24.4% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+388%)	25.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+406%)	30.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+501%)	—	—	—
EPS Growth YoY (%)	N/M	N/M	-75.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-6.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	8.7% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	116.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	94.7% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	—	—	—
Net Income Growth YoY (%)	N/M	N/M	-65.0% Weak ↓ Weak Declining Year-over-year change in net income	-2.1% Weak ↓ Weak Declining Year-over-year change in net income	17.9% Good ↓ Good Declining Year-over-year change in net income	127.8% Excellent ↑ Excellent Improving Year-over-year change in net income	90.2% Excellent Excellent Year-over-year change in net income	25.4% Excellent Excellent Year-over-year change in net income	—	—	—
FCF Growth YoY (%) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Revenue CAGR 3Y (%)	—	—	14.2% Good ↓ Good Declining Compound annual revenue growth over 3 years	17.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	23.1% Excellent Excellent Compound annual revenue growth over 3 years	26.6% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—
Revenue CAGR 5Y (%)	—	—	18.4% Excellent Excellent Compound annual revenue growth over 5 years	21.2% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—
EPS CAGR 3Y (%)	-53.8% Weak ↓ Weak Declining Compound annual EPS growth over 3 years	—	-37.0% Weak ↓ Weak Declining Compound annual EPS growth over 3 years	29.8% Excellent ↓ Excellent Declining Compound annual EPS growth over 3 years	66.1% Excellent Excellent Compound annual EPS growth over 3 years	61.5% Excellent Excellent Compound annual EPS growth over 3 years	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2014 10-K ↗	FY 2015 Mar 27, 2014 10-K ↗
Effective Tax Rate (%) (%)	—	—	—	—	0.9% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.6% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—
Profit Margin (%) (%)	—	—	6.8% Caution ↓ Caution Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-73%)	22.5% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-10%)	24.8% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: At sector avg	25.2% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: At sector avg	13.8% Fair ↑ Fair Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-45%)	9.1% Caution Caution Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-64%)	9.4% Caution Caution Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-62%)	—	—
FCF Margin (%) (%) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FCF / Net Income (x) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2014 10-K ↗	FY 2015 Mar 27, 2014 10-K ↗
Return on Invested Capital (%) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Capital (%) (%)	0.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-0.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	1.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-85%)	-0.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-108%)	1.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-81%)	4.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-45%)	4.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-39%)	4.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-45%)	2.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-70%)	2.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-72%)	1.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-85%)	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2014 10-K ↗	FY 2015 Mar 27, 2014 10-K ↗
Debt to Equity (x)	1.24x Caution ↑ Caution Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+24%)	1.02x Caution ↑ Caution Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: At sector avg	0.79x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-21%)	0.71x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-29%)	0.57x Good → Good Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-43%)	0.49x Good ↓ Good Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-51%)	0.55x Good → Good Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-45%)	0.76x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-24%)	0.33x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-67%)	—	—
Interest Coverage (x) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Debt (USD)	$528.86M	$481.57M	$399.76M	$341.76M	$263.27M	$209.89M	$192.51M	$145.76M	$91.22M	$-2.00K	$0.00
Debt / EBITDA (x) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

📊 What does each share earn? 8 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2014 10-K ↗	FY 2015 Mar 27, 2014 10-K ↗
Revenue per Share (USD)	—	—	$4.48	$4.13	$3.89	$3.51	$3.26	$2.75	$2.52	—	—
Basic EPS, GAAP (USD)	$0.08	$-0.23	$0.20	$0.81	$0.87	$0.80	$0.37	$0.19	$0.19	—	—
Free Cash Flow per Share (USD) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Dividend per Share (USD)	$1.89	$1.84	$1.80	$1.76	$0.43	$0.42	$0.41	$1.60	$1.56	—	—
Book Value per Share (USD)	$15.08	$16.85	$18.59	$19.18	$18.50	$18.00	$16.51	$14.94	$37.30	$0.01	—
Tangible Book Value per Share (USD)	$15.08	$16.85	$18.59	$19.18	$18.50	$18.00	$16.51	$14.94	$37.30	$0.01	—
Basic Weighted Avg Shares (shares)	26.86M	26.53M	25.20M	23.63M	23.26M	21.58M	18.68M	17.67M	14.82M	—	—
Dividend Payout Ratio (%)	2356.2% Weak ↑ Weak Improving Dividends paid as a percentage of earnings Optimal: 30-60%	-802.2% Excellent ↓ Excellent Declining Dividends paid as a percentage of earnings Optimal: 30-60%	902.5% Weak Weak Dividends paid as a percentage of earnings Optimal: 30-60%	217.9% Weak Weak Dividends paid as a percentage of earnings Optimal: 30-60%	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2014 10-K ↗	FY 2015 Mar 27, 2014 10-K ↗
LT Debt (USD)	$532.20M	$485.95M	$403.26M	$353.00M	$265.62M	$212.37M	$194.24M	$147.77M	$93.35M	—	—
Total Equity (USD)	$429.39M	$475.96M	$513.26M	$496.81M	$462.11M	$429.92M	$353.41M	$194.01M	$283.37M	$2.00K	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2014 10-K ↗	FY 2015 Mar 27, 2014 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	$112.84M	$97.68M	$90.58M	$75.68M	$60.85M	$48.56M	$37.34M	—	—
Depreciation Expense (USD)	—	—	—	—	—	—	$22.23M	$19.54M	$18.15M	—	—
Net Income, GAAP (USD)	$5.10M	$-3.18M	$7.71M	$22.02M	$22.49M	$19.08M	$8.38M	$4.40M	$3.51M	—	—
Operating Cash Flow (USD)	$56.43M	$58.88M	$61.38M	$60.28M	$56.35M	$48.37M	$32.36M	$24.44M	$22.13M	—	—

🏛️ Sector-Specific 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2014 10-K ↗	FY 2015 Mar 27, 2014 10-K ↗
FFO (approx.) (USD)	$48.64M	$39.60M	$47.41M	$54.36M	$52.89M	$44.45M	$30.60M	$23.94M	$21.66M	—	—
FFO per Share (approx.) (USD)	$1.81	$1.49	$1.88	$2.30	$2.27	$2.06	$1.64	$1.36	$1.46	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 11 years · 43 quarters

Community Healthcare Trust Inc

Analytical Summary

11-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Dividend History

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare CHCT with peers